Awake Prone Position to Reduce Ventilation Inhomogeneity in COVID-19 Acute Respiratory Failure
NCT ID: NCT04632602
Last Updated: 2021-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2020-04-14
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients
NCT04359407
Prone Position for Nonintubated Patients With COVID-19 and Hypoxemic Respiratory Failure
NCT04641182
Awake Prone Positioning for COVID-19 Acute Hypoxaemic Respiratory Failure
NCT05866289
A Prospective Observational Cohort Study of Awake Prone Position Ventilation Strategy in Patients With Acute Respiratory Failure
NCT05570903
Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure.
NCT05689216
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
1. arm A: prone position followed by dorsal decubitus
2. arm B: dorsal decubitus followed by ventral decubitus A 30-minute wash-out period is set between the end of sequence 1 and the start of sequence 2.
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients in prone position followed by dorsal decubitus
patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours.
physiological effects of awake prone position in COVID 19 patients
Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale).
Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period.
dorsal decubitus followed by prone decubitus
patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours.
physiological effects of awake prone position in COVID 19 patients
Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale).
Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
physiological effects of awake prone position in COVID 19 patients
Study of physiological effects of awake prone position in COVID 19 patients on lung inhomogeneity assessed by Electrical Impedance Tomography (EIT), gas exchange and dyspnea score (Borg Scale).
Measurements will be performed at baseline (on supine position), then patients will be randomized on the order of position, either supine then prone, either prone then supine. Each period will last at least 2 hours. EIT records will be performed during the last 30 minutes of each period, blood gas and dyspnea score at the end of each period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed COVID-19 (positive SARS-CoV-2 RT-PCR at nasopharyngeal swab)
* Acute respiratory failure with 100 \< PaO2:FiO2\< 300 mmhg
* Spontaneous ventilation with standard oxygen supply or high flow humidified oxygen
* Written informed consent of the patient
Exclusion Criteria
* Presence of pacemaker
* Severe hypoxemia with PaO2/FiO2 \< 100 mmHg
* Evidence of clinical signs of respiratory distress with high probability of intubation in the next two hours
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Olivier ARNAUD
Role: STUDY_DIRECTOR
ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assistance Publique Höpitaux de Marseille
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.